Formulation and characterisation of metyrapone suppositories for the first effective long-term use in an infant with McCune-Albright syndrome-related Cushing syndrome

Post time 2024-5-7 22:31:53

journal：European Journal of Hospital Pharmacy

Authors：Gerda Ratzinger-Stoeger; Maria Anzengruber; Katharina Skoll; Diana-Alexandra Ertl; Gabriele Hartmann; Franz Gabor

Published date：--

DOI：10.1136/ejhpharm-2023-003853

PDF link：https://syndication.highwire.org ... jhpharm-2023-003853

Article link：http://dx.doi.org/10.1136/ejhpharm-2023-003853

Article Source：BMJ。

Remark：

Post time 2024-5-7 22:31:54

: This post has been completed
Completed attachments will be deleted within 24 hours.

[BMJ] Formulation and characterisation of metyrapone suppositories for the first effective long-term use in an infant with McCune-Albright syndrome-related Cushing syndrome

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[BMJ] Formulation and characterisation of metyrapone suppositories for the first effective long-term use in an infant with McCune-Albright syndrome-related Cushing syndrome Copy